Ingrid Delaet, Chief Regulatory Officer: Neurocrine Biosciences NBIX Planned sale · Filed 05/29

Trade details

Type: Planned sale notice
Stock: Neurocrine Biosciences NBIX
Person: Ingrid DelaetChief Regulatory Officer
Planned sale date: 26/05/29
Filed: 26/05/29

$353.6K to be sold

Neurocrine Biosciences trades, last 26 weeks

What else happened in Neurocrine Biosciences around then

Filed or reported within 30 days of the trade day · 04/29~06/28

Ingrid Delaet's recent trades

Ingrid DelaetChief Regulatory Officer
Planned sale10b5-1 planNeurocrine Biosciences
Planned sale10b5-1 plan
Neurocrine Biosciences
NBIX
$788.5K
4,367 sh
$788.5K
Filed 07/10
Traded 07/10
Ingrid DelaetChief Regulatory Officer
Planned sale10b5-1 planNeurocrine Biosciences
Planned sale10b5-1 plan
Neurocrine Biosciences
NBIX
$2.5M
14,571 sh
$2.5M
Filed 07/07
Traded 07/07
Ingrid DelaetChief Regulatory Officer
Sell10b5-1 planNeurocrine Biosciences
Sell10b5-1 plan
Neurocrine Biosciences
NBIX
$354.3K
2,261 sh
$354.3K
Filed 06/02
Traded 05/29
Ingrid DelaetChief Regulatory Officer
Sell10b5-1 planNeurocrine Biosciences
Sell10b5-1 plan
Neurocrine Biosciences
NBIX
$61.7K
457 sh
$61.7K
Filed 25/07/11
Traded 25/07/10
Ingrid DelaetChief Regulatory Officer
Planned sale10b5-1 planNeurocrine Biosciences
Planned sale10b5-1 plan
Neurocrine Biosciences
NBIX
$61K
457 sh
$61K
Filed 25/07/10
Traded 25/07/10